NCT00276796View on ClinicalTrials.gov

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2007

Conditions
Cervical Cancer
Interventions
DRUG

cisplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK